QPS Austria GmbH as part of QPS Holdings is a full-service contract research organization (CRO) providing preclinical as well as clinical research services.
About QPS Neuropharmacology
QPS Neuropharmacology offers a sophisticated range of validated transgenic and non-transgenic in vivo and in vitro models for neurodegenerative and rare diseases. These include but are not limited to AD, PD, ALS, HD, MS, Lipid Storage Diseases like NPC1, MPSs and Gaucher, Alport Syndrome, Dyslipidemia, Psychosis, Anxiety, Schizophrenia and Autism.
While many of our models are solely available at QPS Neuropharmacology, all of them are well characterized in house and published in peer-reviewed journals. Besides in vivo and in vitro research we also offer biochemical and histological analyses. To support our clients in the best possible way, we use and adapt existing models, or establish new models specific to your research focus.
The animal facility of QPS Neuropharmacology is AAALAC accredited. This seal of quality combined with over 20 years of experience are a clear asset for our clients, which range from international biotech and pharma companies to academia and other non-profit organizations. Our mission is to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.